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Multilocus sequence typing (MLST) has been successfully applied to the epidemiology of Candida albicans
isolates not only within the hospital setting but also in multiple locations nationwide. We performed MLST to
investigate the genetic relatedness among bloodstream infection (BSI) isolates of C. albicans recovered from 10
Korean hospitals over a 12-month period. The 156 isolates yielded 112 unique diploid sequence types (DSTs).
While 95 DSTs were each derived from a single isolate, 17 DSTs were shared by 61 isolates (39.1%). Inter-
estingly, 111 (71.1%) isolates clustered within previously known clades, and 29 (18.6%) clustered within a new
clade that includes strains of Asian origin previously typed as singletons. This MLST study was complemented
by restriction endonuclease analysis of genomic DNA using BssHII (REAG-B) in order to evaluate whether
strains with identical DSTs and originating from the same hospital corresponded to nosocomial clusters.
Importantly, only those isolates with a strong epidemiological relationship showed >95% identical REAG-B
types. Our results indicate that REAG-B typing can be complementary to MLST but should be limited to the
investigation of isolates of identical DSTs and when interhuman transmission is suspected.
Nosocomial bloodstream infection (BSI) due to Candida
albicans is a significant cause of morbidity and mortality in
hospital patients worldwide (8, 9). C. albicans BSI may be
caused by either a commensal strain carried by the patient
before hospitalization or a strain acquired nosocomially (15,
18, 20, 22). Pfaller et al. demonstrated previously that some C.
albicans BSI strains were more highly concentrated in partic-
ular geographic locales and that established BSI strains were
endemic in some hospitals (15). Because nosocomial BSIs due
to C. albicans constitute an important issue, it has proven quite
important to achieve a precise understanding of its epidemiol-
ogy by use of a reliable typing system (2, 5, 13, 18, 20). Several
molecular typing methods have been used to track endemic or
epidemic C. albicans clones (3). These methods include South-
ern blot hybridization with discriminating probes, electropho-
retic karyotyping (EK), restriction fragment length polymor-
phism (RFLP) analysis, randomly amplified polymorphic DNA
(RAPD) analysis, and multilocus sequence typing (MLST).
MLST was developed to meet the increasing need for global
surveillance and for the comparison of genotypes in a central
database accessed via the Internet (2–5, 14). MLST is easy to
perform and can group C. albicans isolates in a manner similar
to that of Ca3 Southern hybridization (6). The results of MLST
are unambiguous, and sequence data obtained from different
hospitals can be shared and compared (3). However, because
MLST analyzes the sequences of seven 300- to 400-bp loci
only, isolates with identical diploid sequence types (DSTs) may
differ substantially through large genomic rearrangements in
regions that do not encompass the sequenced loci (loss of
heterozygosity, aneuploidies, and chromosome size polymor-
phisms) as well as in the haplotype structures at the sequenced
loci (3, 7, 16). Thus, isolates of identical MLST types may need
further genotypic characterization to assess clonal relation-
ships. In this respect, two previous studies used MLST analysis
for the genotyping of C. albicans BSI isolates from different
hospitals (2, 13). Both studies identified some strains of iden-
tical DSTs, but these were not further characterized.
The present study was performed to investigate the genetic
relatedness among C. albicans BSI isolates from 10 Korean
hospitals. We first analyzed MLST data for 156 C. albicans
strains isolated from 10 hospitals over a 12-month period.
Subsequently, we assessed the genotypic diversity among C.
albicans isolates with the same DSTs by restriction digestion
analysis of genomic DNA using BssHII (REAG-B) followed by
pulsed-field gel electrophoresis (PFGE), which has proven use-
ful for the discrimination of C. albicans isolates (17, 18, 21, 22).
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This is, to our knowledge, the first reported nationwide study
analyzing genotypic relationships among C. albicans BSI iso-
lates from South Korea by both MLST and REAG-B typing.
MATERIALS AND METHODS
C. albicans BSI isolates. A prospective surveillance study was conducted at 10
university hospitals (hospitals A to J) located throughout South Korea over a
12-month period to assess genotypic relationships among C. albicans BSI iso-
lates. BSI isolates were collected between September 2006 and August 2007 from
blood cultures by the method(s) in routine use in each laboratory. Duplicate
isolates of C. albicans from the same patient were excluded. During the study
period, nosocomial clusters were not reported by the hospital surveillance teams
in any of the 10 hospitals.
In total, 156 C. albicans BSI isolates from 156 patients were submitted to the
Chonnam National University Hospital for genotyping. The identification of
isolates to the species level was based on colony morphology on CHROMagar
Candida (BBL, Becton Dickinson, Sparks, MD) at 35°C, microscopic morphol-
ogy on cornmeal-Tween 80 agar, and a commercially available biochemical
identification system (API 20C [bioMe´rieux, Marcy L’Etoile, France] or the
Vitek 2 system Vitek 2 ID-YST [bioMe´rieux]).
MLST analysis. C. albicans isolates were typed by using an MLST scheme
described previously (4). The internal regions of seven housekeeping genes
(AAT1a, ACC1, ADP1, MPIb, SYA1, VPS13, and ZWF1b) were sequenced. Se-
quence analysis was performed on both strands by use of an ABI Prism 3130xl
genetic analyzer (Applied Biosystems, Foster City, CA). Each strain was char-
acterized by a DST resulting from the combination of the genotypes obtained at
the seven loci. MLST data have been deposited at the MLST database (http:
//calbicans.mlst.net). Clades were defined and numbered as described previously
(12, 14). Isolates that did not cluster with a known clade and clusters containing
fewer than 10 isolates were labeled as singletons. A dendrogram was constructed
by use of the unweighted-pair group method using average linkages (UPGMA)
and the MEGA 4 software package, as described previously (19). Numbers at
nodal points indicate bootstrap values (percent) for 1,000 replications.
REAG-B typing. REAG-B typing was performed through PFGE of genomic
DNA cleaved using the restriction endonuclease BssHII as described previously
(17, 18). Isolates were considered identical when all bands observed by PFGE
matched. Banding patterns with95% but less than 100% of the bands matching
were termed “similar” and grouped into subtypes (subtype a, b, or c) of a given
REAG-B type. Isolates with less than 95% of bands matching were considered
different (10, 18, 21). All analyses were performed at least twice.
RESULTS
A prospective surveillance study was conducted at 10 uni-
versity hospitals (hospitals A to J) (Table 1) located through-
out South Korea over a 12-month period. In total, 156 C.
albicans BSI isolates from 156 patients were obtained and
typed by MLST using a combination of seven housekeeping
genes. One hundred twelve unique DSTs were obtained from
the 156 C. albicans BSI isolates. Sixty-five isolates (41.7%)
belonged to previously described types (29 DSTs), whereas 91
(58.3%) belonged to 83 novel DSTs. In order to assign the
Korean isolates to existing clades, we performed an analysis of
these isolates together with 1,003 DSTs retrieved from the
MLST database (55% of all DSTs currently available in the
MLST database [http://calbicans.mlst.net]). Nine hundred fifty-
nine of the 1,003 DSTs had been previously assigned to one of
17 clades, and 44 had been classified as singletons. Of 156
Korean BSI isolates, 111 (71.1%) isolates clustered within
known clades (clades 1 to 17), while 45 (28.9%) did not cluster
within these clades. Noticeably, among the unclassified iso-
lates, 29 (18.6%) clustered within a single, highly structured
group (Fig. 1A), which corresponded to a new clade, as it
contained more than 10 different DSTs that clustered within a
0.035 threshold, which we used to define clades (see Discus-
sion; also see Fig. S1 in the supplemental material). As shown
in Fig. 1B, this new clade included 35 of the 1,159 isolates and
had a high level of bootstrap support (0.76). Strikingly, 5 of 13
singletons corresponding to isolates originating from Asia clus-
tered within this new clade, while only 1 of 31 singletons with
a non-Asian origin clustered within the new clade (Fig. 1B).
These data suggested that the new clade identified in our study
is highly enriched for isolates of Asian origin if not specific to
Asia.
Figure 1C illustrates the UPGMA dendrogram based on
MLST data for the 156 C. albicans isolates and their clade
assignments, and Table 1 presents the clade distribution of the
156 C. albicans BSI isolates from the 10 hospitals. The novel
clade contained the greatest proportion of isolates (18.6%),
followed by clade 4 (15.4%), clade 1 (14.7%), clade 12
(11.5%), and clade 8 (8.3%). Within each hospital, isolates
from 4 to 11 different clades were found.
Of 112 DSTs, 95 (60.9%) were unique to a single isolate, and
17 (39.1%) were shared among 61 isolates. DSTs, hospital and
TABLE 1. MLST results for 156 C. albicans bloodstream isolates from 156 patients from 10 Korean hospitals
Clade No. (%) ofisolates
No. of isolates in hospital: No. of
DSTsA B C D E F G H I J
1 23 (14.7) 5 5 2 3 2 2 4 17
4 24 (15.4) 8 2 6 2 3 2 1 21
5 5 (3.2) 1 1 1 1 1 5
6 5 (3.2) 1 2 1 1 5
8 13 (8.3) 5 3 1 1 1 1 1 9
9 4 (2.6) 2 2 4
10 2 (1.3) 1 1 2
11 6 (3.8) 1 1 2 1 1 5
11b 4 (2.6) 3 1 2
12 18 (11.5) 3 4 1 1 1 2 2 2 2 12
14 1 (0.6) 1 1
15 5 (3.2) 2 1 1 1 3
16 1 (0.6) 1 1
New clade 29 (18.6) 8 7 5 3 1 1 4 11
Singletons 16 (10.3) 3 4 2 2 2 2 1 14
Total 156 (100.0) 42 25 23 12 11 10 9 8 8 8 112
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ward of origin, and date of isolation for each of these 61
isolates are shown in Table 2. DST 727 was shared by 13
isolates, DST 732 and DST 69 were shared by 7 isolates, DST
601 was shared by 6 isolates, and DST 365 was shared by 4
isolates (Table 2). The remaining 12 DSTs accounted for two
isolates each (Table 2). Overall, 32.8% of these 61 isolates
accounted for DSTs 727 and 732, which belonged to the same
(novel) clade. Noticeably, 26 of these isolates formed groups of
two, three, or four isolates each originating from a single hos-
pital, representing 11 potential nosocomial clusters (DST 69,
isolates 1 and 2; DST 601, isolates 1 and 2; DST 727, isolates
1 to 3, 4 to 6, 7 to 10, 12, and 13; DST 732, isolates 1 and 2;
DST 1512, isolates 1 and 2; DST 1563, isolates 1 and 2; DST
1608, isolates 1 and 2; and DST 1627, isolates 1 and 2) (Table
2). These 26 isolates, as well as the other 35 isolates with
identical DSTs, were further characterized by REAG-B typing,
yielding 54 different REAG-B patterns (Fig. 2 and Table 2). Of
the 11 groups of strains with identical DSTs and each origi-
FIG. 1. MLST analysis of Korean C. albicans isolates identifies a novel clade. (A) UPGMA dendrogram for 1,159 C. albicans isolates. The 17
clades (clades 1 to 17) and the new Asia-specific clade (NC) are indicated. (B) Details of the UPGMA dendrogram of A showing relationships
between 35 isolates of the new Asia-specific clade. Boxed isolates identify singletons retrieved from the MLST database, and their origins are
indicated. Numbers at nodal points indicate bootstrap values (percent) for 1,000 replications. (C) UPGMA dendrogram showing the genetic
relatedness among 156 BSI isolates of C. albicans by use of MLST typing. The vertical bar to the right of each cluster indicates the clade or singleton
designation. The scale indicates p-distances.
TABLE 2. REAG-B results for 61 bloodstream isolates sharing 17 DSTsa
DST Hospital Isolate Department/ward Isolation date(mo/day/yr)
REAG-B
type DST Hospital Isolate Department/ward
Isolation date
(mo/day/yr)
REAG-B
type
69 H 1 NS/SICU 07/01/2007 R1 E 11 IM/61W 08/28/2006 R30
H 2b PUL/32W 08/25/2007 R2a C 12 ONC/72W 11/11/2006 R31
B 3b IM/80W 12/09/2006 R2b C 13 GE/184W 07/02/2007 R32
C 4 IM/MICU 04/08/2007 R3
D 5b IM/80W 01/12/2007 R4a 732 C 1 PUL/83W 08/02/2007 R33
E 6b IM/ICU 07/02/2007 R2c C 2b ONC/MICU 07/05/2007 R34a
F 7b HEM/50W 08/22/2007 R4b A 3b HEM/24W 09/02/2006 R34b
B 4 PUL/MICU 02/16/2007 R35
365 A 1 HEM/36W 06/10/2007 R5 H 5 HEM/SICU 12/17/2006 R36
G 2 IM/10W 12/28/2006 R6 E 6 GS/51W 10/30/2006 R37
F 3 HEM/16W 05/09/2007 R7 F 7 GS/70W 06/11/2006 R38
C 4 ONC/MICU 08/10/2007 R8
929 B 1 NEP/ICU 04/05/2007 R39
461 A 1 IM/23W 08/30/2007 R9 I 2 PUL/ICU 07/24/2007 R40
J 2 PUL/MICU 06/14/2007 R10
1512 A 1b,c NEP/ICU B 10/07/2006 R41
601 B 1 NR/109W 09/01/2006 R11 A 2b,c PUL/ICU B 10/07/2006 R41
B 2 CV/MICU 09/21/2006 R12
F 3 GE/5W 06/06/2007 R13 1538 A 1 IM/23W 08/07/2007 R42
G 4 GS/3W 06/05/2007 R14 J 2 ONC/MICU 03/31/2007 R43
H 5 GE/ER 04/11/2007 R15
I 6 GS/ICU 04/02/2007 R16 1563 D 1b,c GS/90W 09/13/2006 R44a
D 2b,c GS/90W 09/22/2006 R44b
659 D 1b IM/80W 11/13/1007 R17a
J 2b NEP/9W 08/11/2007 R17b 1575 C 1 PED/62W 05/29/2007 R45
I 2 NS/9W 02/20/2007 R46
719 A 1 HEM/45W 04/30/2007 R18
G 2 IM/6W 10/06/2006 R19 1608 F 1 GS/69W 11/26/2006 R47
F 2 HEM/17W 01/26/2007 R48
727 A 1 GS/191W 04/17/2007 R20
A 2 ONC/45W 08/14/2007 R21 1609 F 1 HEM/16W 04/05/2007 R49
A 3 PED/78W 08/17/2007 R22 A 2 ONC/35W 06/30/2007 R50
B 4 GS/SICU 09/15/2006 R23
B 5 CV/87W 05/30/2007 R24 1614 A 1 ONC/36W 10/15/2006 R51
B 6 GE/89W 08/04/2007 R25 D 2 IM/80W 12/18/2006 R52
J 7 PED/SICU 09/25/2006 R26
J 8 GS/52W 01/09/2007 R27 1627 A 1 PUL/ICU 01/07/2007 R53
J 9 NEP/MICU 03/10/2007 R28 A 2 IM/101W 06/20/2007 R54
J 10 PUL/102W 07/23/2007 R29
a REAG-B, restriction endonuclease analysis of genomic DNA using BssHII; NS, neurosurgery; SICU, surgical intensive care unit; PUL, pulmonology; IM, internal
medicine; MICU, medical intensive care unit; HEM, hematology; ONC, oncology; NR, neurology; CV, cardiology; GE, gastroenterology; GS, general surgery; PED,
pediatrics; NEP, nephrology. Two- or three-number designations prefixed to the letter “W” represent ward numbers.
b Six sets of isolates (DST 69, isolates 2, 3, and 6; DST 69, isolates 5 and 7; DST 659, isolates 1 and 2; DST 732, isolates 2 and 3; DST 1512, isolates 1 and 2; DST
1563, isolates 1 and 2) with the same DSTs were similar by REAG-B typing (95% of the bands matched by REAG-B).
c The same DSTs and indistinguishable REAG-B patterns in two patient isolates from the same hospital suggest a nosocomial cluster.
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nating from a single hospital, only 1 had isolates with identical
REAG-B patterns (DST 1512, isolates 1 and 2), and 1 had
isolates with similar REAG-B patterns (DST 1563, isolates 1
and 2). The other nine groups contained two, three, or four
isolates with different REAG-B patterns. Interestingly, while
DST 1512 or 1563 isolates had been recovered from two pairs
of patients who were concurrently hospitalized in the same
ward, other isolates with identical DSTs and from the same
hospitals had been isolated in different wards, most at an in-
terval of more than 2 months (Table 2). Finally, it should be
noted that isolates with identical DSTs and identical or closely
related REAG-B patterns and originating from different hos-
pitals were also observed (DST 69, isolates 2, 3, and 6; DST 69,
isolates 5 and 7; DST 659, isolates 1 and 2; DST 732, isolates
2 and 3) (Table 2).
DISCUSSION
C. albicans isolates can be assigned by MLST to subsets of
closely related strain types, referred to as clades (12, 14).
Clades have been defined as clusters of at least 10 isolates with
DSTs that have a p-distance below 0.04, while their p-distance
with DSTs outside the clade is above 0.04. In this respect, a
previously reported analysis of MLST data for 1,391 C. albi-
cans isolates corresponding to 1,005 unique DSTs by Odds et
al. (14) allowed the assignment of 97% of these isolates to one
of 17 clades, with the remaining 3% being defined as single-
tons. Clade 1 accounted for the largest proportion of isolates
(33.6%). As shown in Fig. S1 in the supplemental material,
when a panel of 1,005 DSTs already assigned to clades (14) was
combined with the 112 DSTs identified in our study, the p-dis-
tance threshold of 0.04 used by Odds et al. to define clades
could not resolve clades 2 and 4, whereas a threshold of 0.035
slit clades 2 and 4. This suggested that the threshold used for
clade assignments was somewhat reliant on the sample studied
and that p-distances between 0.04 and 0.035 should be used to
separate clades, provided that they include at least 10 DSTs.
On these grounds, only 71.1% of 156 BSI isolates of Korean
origin clustered within 12 of the 17 known clades. Significantly,
a minority of the 156 isolates (29 isolates; 18.6%) belonged to
the new MLST clade. It is noteworthy that 6 DSTs previously
labeled as singletons belong to this new clade and that 5 of
these 6 DSTs correspond to isolates of Asian origin (China,
South Korea, Japan, and Hong Kong). As the sample of DSTs
that we have analyzed contained 44 singletons, 13 of which
originated from Asia, we hypothesize that the new clade re-
vealed by our analysis of Korean isolates corresponds to an
Asia-specific clade. If this hypothesis holds true, it is, to our
knowledge, the first time that a clade with such a geographical
specificity would have been identified within the C. albicans
population. Indeed, while clades show some enrichment for
isolates from a specific geographical origin, most of them in-
clude isolates from a multitude of geographical origins (14).
Therefore, the identification of this new clade supports the
hypothesis that C. albicans clades have a geographical origin
that is being blurred by the increased traveling of human pop-
ulations over recent years (11). Surprisingly, none of the 156
isolates characterized in this study could be assigned to clade 3,
one of the major clades identified by all other studies (11, 14).
However, Fig. 1A shows that the new clade is closely related to
clade 3. Therefore, it cannot be excluded that the new clade,
despite meeting the criteria for clade definition, constitutes a
subgroup of clade 3 including mainly Asian strains.
An analysis limited to European isolates, thereby minimiz-
ing geographical effects, suggested that the proportion of iso-
lates from blood, commensal carriage, and superficial infec-
tions differed between the most populous clades (14).
Interestingly, 79.5% of the 327 BSI isolates characterized pre-
viously by Odds et al. (14) fell into one of the five major clades
FIG. 2. Representative PFGE patterns of C. albicans obtained by restriction endonuclease analysis of genomic DNA using BssHII (REAG-B).
See Table 2 for detailed information on each isolate. Two isolates belonging to the same DST (DST 1512 and DST 1563), which were from the
same hospital, showed indistinguishable REAG-B patterns. However, other isolates belonging to the same DST displayed patient-specific PFGE
genotypes (less than 95% of the bands matching). T, C. albicans ATCC 90028; M, Saccharomyces cerevisiae DNA concatemers as a molecular size
marker.
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(clades 1 to 4 and 11). This is in contrast with our observation
that only 34% of the 156 Korean BSI isolates belong to these
major clades. This might represent differences in the clade
distribution of C. albicans isolates circulating in South Korea
and Europe. Further characterization of non-BSI isolates in
South Korea will be required to assess whether this difference
is also influenced by the origins of our BSI isolates.
In this study, we have performed REAG-B typing for the
further characterization of isolates indistinguishable by MLST.
Our data show that most isolates with identical DSTs and
originating from different hospitals have different REAG-B
types, demonstrating that REAG-B typing can be used to fur-
ther differentiate C. albicans BSI isolates of identical DSTs.
However, four sets of two or three isolates from different
hospitals remained indistinguishable by MLST and REAG-B
typing. Although this may suggest the interhospital transfer of
C. albicans strains, it is more likely to reflect the predominance
of some DSTs in the global C. albicans population. Indeed,
DST 69 and DST 659 have been shown to occur at a higher
frequency than any other DST worldwide (14), and DST 732
was one of the two predominant DSTs in the novel Korean-
specific clade. These data are consistent with data from a study
reported previously by Odds et al. (13), who performed MLST
typing on C. albicans BSI isolates (n  152) in Scotland and
suggested that the occurrence of BSI isolates with identical
DSTs obtained from hospitals in different cities was unlikely to
be the result of interhospital strain transmission.
The characterization by REAG-B typing of putative noso-
comial clusters, i.e., a group of two or more isolates originating
from the same hospital, showed that 9 of these clusters con-
tained isolates with different REAG-B types and that 2 con-
tained isolates with 95% identical REAG-B types. Impor-
tantly, the former 9 clusters included isolates collected from
different wards and/or more than 2 months apart, while the
latter 2 clusters included isolates sampled in the same ward
and at the same time. Therefore, it is likely that the former 9
clusters do not represent nosocomial clusters and include
strains with identical DSTs but different epidemiological ori-
gins, while the latter 2 clusters represent possible nosocomial
clusters. However, this interpretation should be taken with
caution, as REAG-B patterns are likely to reflect fast-evolving
genetic markers, and it cannot be excluded that isolates with
identical DSTs and different REAG-B types could neverthe-
less be derived from a common recent ancestor. Therefore,
REAG-B typing of isolates with identical DSTs should be used
preferentially for isolates most likely to belong to a nosocomial
cluster, i.e., those identified in a same ward or at about the
same time in the same hospital.
These data suggested that nosocomial clusters were rela-
tively rare in our sample. This is in contrast with data from a
recent study from Iceland, where as many as 23% of all cases
of C. albicans BSI were attributable to nosocomial clusters (1).
However, it should be noted that that study used RAPD typing,
which has lower discriminatory power and reproducibility than
MLST and REAG-B typing and may consequently overesti-
mate the incidence of identical isolates.
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